Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

Barbui T, Vannucchi AM, De Stefano V, Carobbio A, Ghirardi A, Carioli G, Masciulli A, Rossi E, Ciceri F, Bonifacio M, Iurlo A, Palandri F, Benevolo G, Pane F, Ricco A, Carli G, Caramella M, Rapezzi D, Musolino C, Siragusa S, Rumi E, Patriarca A, Cascavilla N, Mora B, Cacciola E, Mannarelli C, Loscocco GG, Guglielmelli P, Gesullo F, Betti S, Lunghi F, Scaffidi L, Bucelli C, Vianelli N, Bellini M, Finazzi MC, Tognoni G, Rambaldi A

Open source

DOI: 10.1056/evidoa2200335
Published: 2023 Jun
Container: NEJM evidence
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2200335,
  title = {Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.},
  author = {Barbui T and Vannucchi AM and De Stefano V and Carobbio A and Ghirardi A and Carioli G and Masciulli A and Rossi E and Ciceri F and Bonifacio M and Iurlo A and Palandri F and Benevolo G and Pane F and Ricco A and Carli G and Caramella M and Rapezzi D and Musolino C and Siragusa S and Rumi E and Patriarca A and Cascavilla N and Mora B and Cacciola E and Mannarelli C and Loscocco GG and Guglielmelli P and Gesullo F and Betti S and Lunghi F and Scaffidi L and Bucelli C and Vianelli N and Bellini M and Finazzi MC and Tognoni G and Rambaldi A},
  year = {2023},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2200335},
  url = {https://doi.org/10.1056/evidoa2200335}
}

RIS

TY  - JOUR
TI  - Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
AU  - Barbui T
AU  - Vannucchi AM
AU  - De Stefano V
AU  - Carobbio A
AU  - Ghirardi A
AU  - Carioli G
AU  - Masciulli A
AU  - Rossi E
AU  - Ciceri F
AU  - Bonifacio M
AU  - Iurlo A
AU  - Palandri F
AU  - Benevolo G
AU  - Pane F
AU  - Ricco A
AU  - Carli G
AU  - Caramella M
AU  - Rapezzi D
AU  - Musolino C
AU  - Siragusa S
AU  - Rumi E
AU  - Patriarca A
AU  - Cascavilla N
AU  - Mora B
AU  - Cacciola E
AU  - Mannarelli C
AU  - Loscocco GG
AU  - Guglielmelli P
AU  - Gesullo F
AU  - Betti S
AU  - Lunghi F
AU  - Scaffidi L
AU  - Bucelli C
AU  - Vianelli N
AU  - Bellini M
AU  - Finazzi MC
AU  - Tognoni G
AU  - Rambaldi A
PY  - 2023
JO  - NEJM evidence
DO  - 10.1056/evidoa2200335
UR  - https://doi.org/10.1056/evidoa2200335
ER  -

APA

T, B., AM, V., V, D. S., A, C., A, G., G, C., A, M., E, R., F, C., M, B., A, I., F, P., G, B., F, P., A, R., G, C., M, C., D, R., C, M., S, S., E, R., A, P., N, C., B, M., E, C., C, M., GG, L., P, G., F, G., S, B., F, L., L, S., C, B., N, V., M, B., MC, F., G, T., & A, R. (2023). Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.. NEJM evidence. https://doi.org/10.1056/evidoa2200335

Source records

pubmed · retrieved 2026-09-27T09:48:41.683Z